DocuSign, Inc.DOCUNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-16.3%
5Y CAGR-22.4%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-16.3%/yr
vs -31.6%/yr prior
5Y CAGR
-22.4%/yr
Recent acceleration
Acceleration
+15.3pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202613.01%
20259.08%
202412.26%
202322.17%
202244.87%
202146.33%
2020-0.22%
2019101.20%
20183.10%
201744.01%